Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study-Reference-Cited by-同舟云学术

Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study

Published:2015-09 Issue:13 Volume:51 Page:1660-1666
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Pivot Xavier,Suter Thomas,Nabholtz Jean Marc,Pierga Jean Yves,Espie Marc,Lortholary Alain,Khayat David,Pauporte Iris,Romieu Gilles,Kramar Andrew,Fumoleau Pierre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer;Perez;J Clin Oncol,2011

2. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

3. Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

4. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

5. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer;JAMA Network Open;2024-08-26

2. Genetic factors in the pathogenesis of cardio-oncology;Journal of Translational Medicine;2024-08-05

3. Prevention of anthracycline and trastuzumab‐induced decline in left ventricular ejection fraction with angiotensin‐converting enzyme inhibitors or angiotensin receptor blocker: a narrative systematic review of randomised controlled trials;Internal Medicine Journal;2024-06-14

4. Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis;Revista Portuguesa de Cardiologia;2023-12

5. Characteristics and research status among clinical trials in cardio‐oncology by bibliometric and visualized analysis;Cancer Medicine;2023-05-06